Atıf İçin Kopyala
Gurkan-Alp A. S., Alp M., Karabay A. Z., Koç A., Buyukbingol E.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, cilt.20, sa.14, ss.1728-1738, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
20
Sayı:
14
-
Basım Tarihi:
2020
-
Doi Numarası:
10.2174/1871520620666200502001953
-
Dergi Adı:
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.1728-1738
-
Anahtar Kelimeler:
Benzimidazole, breast cancer, cancer, docking, PARP-1 inhibitors, olaparib, INHIBITORS, DERIVATIVES, OLAPARIB
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background: Poly (ADP-ribosyl) polymerase-1 (PARP-1) inhibitors are compounds that are used to treat cancers, which are defective in DNA-repair and DNA Damage-Response (DDR) pathways.